HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$2.51
Day range
$2.38 - $2.58
Year range
$1.90 - $6.08
Market cap
204.63M USD
Avg Volume
693.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.54M | -55.82% |
Operating expense | 12.36M | -3.93% |
Net income | -20.69M | -79.82% |
Net profit margin | -274.27 | -306.99% |
Earnings per share | -0.25 | -56.25% |
EBITDA | -19.29M | -81.37% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.78M | -30.09% |
Total assets | 128.89M | -13.82% |
Total liabilities | 79.26M | 12.76% |
Total equity | 49.63M | — |
Shares outstanding | 82.84M | — |
Price to book | 4.18 | — |
Return on assets | -36.86% | — |
Return on capital | -43.41% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -20.69M | -79.82% |
Cash from operations | -13.80M | -77.15% |
Cash from investing | 11.77M | 141.20% |
Cash from financing | 1.08M | -96.29% |
Net change in cash | -944.00K | 86.65% |
Free cash flow | -6.62M | -22.82% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
188
